Introducing The Pharma Letter

The Marketletter website you have tried to access has ceased operations.

We would like to introduce you to this new online publication, The Pharma Letter, that has been set up with the former Marketletter and Scrip News founding Editor, Barbara Obstoj, and supporting team.

The Pharma Letter will provide you with daily insightful opinion and analysis on the pharmaceutical and biotechnology industries and free access to the archive content dating back to 1992.

To find out more and access the following, why not take a trial:

• Manage your profile and email preferences
• Get unlimited access to our new website with up-to-the minute news
• Benefit from a daily news email alert, with the breaking stories
• Engage in online discussion forums and Q&A
• Network with pharma and biotech industry experts
• Much, much more!

If you had a current subscription to Marketletter please contact us.